Sambria Pharmaceuticals

www.sambriapharma.com

Sambria Pharmaceuticals, LLC is a consumer healthcare products and pharmaceutical development firm that markets innovative, OTC pain relief and related topically administered medications that address the growing needs of clinicians and patients. Sambria Pharmaceutical's innovative trans-dermal delivery system provides for rapid onset of action and deep penetration of therapeutics that under typical conditions have limited cutaneous absorption, in particular topical anesthetics such as lidocaine, benzocaine, tetracaine and others in the amino benzoate and amino ester anesthetic class of drugs. Sambria's current focus is providing its rapid onset of action topical anesthetic to the dermatology, podiatry, pediatric, cosmetic/aesthetic medicine and other specialties where rapid onset of anesthetic serves the clinician and patient needs. If you are a clinician within these specialties and have an interest in learning about Sambria's rapid onset, trans-dermal permeation enhanced topical anesthetics, please feel free to contact us via email at [email protected] or call directly 888.246.6601. Sambria is currently seeking highly motivated, skilled independent representatives and distributors who have established relationships and a proven track record of success. To be considered for an independent rep position among the growing Sambria team, please contact us through email directly to [email protected]. There are still territories in regions throughout the United States.

Read more

Reach decision makers at Sambria Pharmaceuticals

Lusha Magic

Free credit every month!

Sambria Pharmaceuticals, LLC is a consumer healthcare products and pharmaceutical development firm that markets innovative, OTC pain relief and related topically administered medications that address the growing needs of clinicians and patients. Sambria Pharmaceutical's innovative trans-dermal delivery system provides for rapid onset of action and deep penetration of therapeutics that under typical conditions have limited cutaneous absorption, in particular topical anesthetics such as lidocaine, benzocaine, tetracaine and others in the amino benzoate and amino ester anesthetic class of drugs. Sambria's current focus is providing its rapid onset of action topical anesthetic to the dermatology, podiatry, pediatric, cosmetic/aesthetic medicine and other specialties where rapid onset of anesthetic serves the clinician and patient needs. If you are a clinician within these specialties and have an interest in learning about Sambria's rapid onset, trans-dermal permeation enhanced topical anesthetics, please feel free to contact us via email at [email protected] or call directly 888.246.6601. Sambria is currently seeking highly motivated, skilled independent representatives and distributors who have established relationships and a proven track record of success. To be considered for an independent rep position among the growing Sambria team, please contact us through email directly to [email protected]. There are still territories in regions throughout the United States.

Read more
icon

Country

icon

State

Georgia

icon

City (Headquarters)

Atlanta

icon

Employees

1-10

icon

Founded

2012

icon

Estimated Revenue

$1 to $1,000,000

icon

Social

  • icon

Employees statistics

View all employees

Potential Decision Makers

  • Chief Operations Officer

    Email ****** @****.com
    Phone (***) ****-****
  • Chief Executive Officer

    Email ****** @****.com
    Phone (***) ****-****

Technologies

(12)

Reach decision makers at Sambria Pharmaceuticals

Free credits every month!

My account

Sign up now to uncover all the contact details